光云科技：2025年前三季度净利润约-1503万元

Group 1 - Company reported Q3 performance with revenue of approximately 405 million yuan, a year-on-year increase of 14.87% [1] - The net profit attributable to shareholders was a loss of approximately 15.03 million yuan, with basic earnings per share showing a loss of 0.04 yuan [1] - As of the report date, the company's market capitalization stood at 6.2 billion yuan [2] Group 2 - The Chinese innovative drug sector has seen significant overseas licensing sales reaching 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a fundraising slowdown [2]